$HSGX, Histogenics Files 8K - Other Events >HSG
Post# of 23083
(Total Views: 59)
Posted On: 05/08/2017 8:19:53 AM
$HSGX,
Histogenics Files 8K - Other Events >HSGX
1 hour 17 minutes ago - DJNF
Histogenics Corp. (HSGX) filed a Form 8K - Other Events - with the U.S Securities and Exchange Commission on May 08, 2017.
On May 8, 2017, Histogenics Corporation ("Histogenics"
issued a press release announcing that it has successfully completed all formal consultations with the Office of Cellular and Tissue-based Products of the Japan Pharmaceuticals and Medical Devices Agency regarding the Marketing and Manufacturing Authorization pathway for Histogenics' NeoCart (R) (autologous cell therapy designed to treat cartilage defects in the knee) in the Japanese market.
The press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.
The full text of this SEC filing can be retrieved at: http://www.sec.gov/Archives/edgar/data/137229...925d8k.htm
Any exhibits and associated documents for this SEC filing can be retrieved at: http://www.sec.gov/Archives/edgar/data/137229...-index.htm
Public companies must file a Form 8-K, or current report, with the SEC generally within four days of any event that could materially affect a company's financial position or the value of its shares.
(END) Dow Jones Newswires
May 08, 2017 07:01 ET (11:01 GMT)
Copyright (c) 2017 Dow Jones & Company, Inc.
Histogenics Files 8K - Other Events >HSGX
1 hour 17 minutes ago - DJNF
Histogenics Corp. (HSGX) filed a Form 8K - Other Events - with the U.S Securities and Exchange Commission on May 08, 2017.
On May 8, 2017, Histogenics Corporation ("Histogenics"
issued a press release announcing that it has successfully completed all formal consultations with the Office of Cellular and Tissue-based Products of the Japan Pharmaceuticals and Medical Devices Agency regarding the Marketing and Manufacturing Authorization pathway for Histogenics' NeoCart (R) (autologous cell therapy designed to treat cartilage defects in the knee) in the Japanese market. The press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.
The full text of this SEC filing can be retrieved at: http://www.sec.gov/Archives/edgar/data/137229...925d8k.htm
Any exhibits and associated documents for this SEC filing can be retrieved at: http://www.sec.gov/Archives/edgar/data/137229...-index.htm
Public companies must file a Form 8-K, or current report, with the SEC generally within four days of any event that could materially affect a company's financial position or the value of its shares.
(END) Dow Jones Newswires
May 08, 2017 07:01 ET (11:01 GMT)
Copyright (c) 2017 Dow Jones & Company, Inc.
(0)
(0)
I'm in it to win it!
NASDAQ DIP and RIP
Here is the best word that describes what i do here.
Intuitive;
means having the ability to understand or know something without any direct evidence or reasoning process.
I was born with it, I'm truly blessed!
Alway's searching for winners'
NASDAQ DIP and RIP
Here is the best word that describes what i do here.
Intuitive;
means having the ability to understand or know something without any direct evidence or reasoning process.
I was born with it, I'm truly blessed!
Alway's searching for winners'